Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-03

Clinical Trial Update: A Study of LY3437943 in Participants With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for LY3437943 in participants with type 2 diabetes has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY3437943

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2023-07-03